Publication | Closed Access

Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas

Neuro-oncologyOncologyTumor HeterogeneityMedicineIdh 1/2Predict Patient PrognosisPathologyCancer GenomicsHigh-grade GliomasCancer GeneticsRadiation OncologyMolecular DiagnosticsGliomaMolecular OncologyHealth Sciences